“…Additionally, it was shown that the overexpression of HNF4α in rodent HCC models blocks carcinogenesis and metastasis (Yin et al, 2008;Ning et al, 2010). In previous studies, we and others have shown that CAR diminished the association of HNF4α with its specific binding site in gene promoters (Miao et al, 2006;Kachaylo et al, 2012;Yarushkin et al, 2013). Similar to these previous studies, we demonstrated that TCPOBOP, direct agonist of CAR, produced a significant decrease in the level of miR-122, a HNF4α target, by competing with HNF4α for binding to the DR1 motif in pri-miR-122 promoter.…”